Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 1
1957 1
1961 2
1964 3
1965 2
1967 1
1969 4
1970 1
1971 6
1972 5
1973 11
1974 10
1975 3
1976 4
1977 2
1978 2
1979 1
1980 2
1982 10
1983 3
1984 7
1985 8
1986 6
1987 4
1988 7
1989 10
1990 5
1991 7
1992 8
1993 10
1994 10
1995 11
1996 9
1997 10
1998 14
1999 17
2000 6
2001 11
2002 7
2003 9
2004 6
2005 9
2006 10
2007 5
2008 8
2009 8
2010 13
2011 10
2012 9
2013 18
2014 10
2015 9
2016 7
2017 9
2018 1
2019 4
2020 2
2021 7
2022 8
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

384 results
Results by year
Filters applied: . Clear all
Page 1
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial.
Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators. Teng E, et al. JAMA Neurol. 2022 Aug 1;79(8):758-767. doi: 10.1001/jamaneurol.2022.1375. JAMA Neurol. 2022. PMID: 35696185 Free PMC article. Clinical Trial.
The Good and Bad Sides of NAAG.
Khacho P, Wang B, Bergeron R. Khacho P, et al. Among authors: bergeron r. Adv Pharmacol. 2016;76:311-49. doi: 10.1016/bs.apha.2016.01.003. Epub 2016 Mar 2. Adv Pharmacol. 2016. PMID: 27288081 Review.
Metabolically programmed iron chelators.
Bergeron RJ, Bharti N, McManis JS, Wiegand J. Bergeron RJ, et al. Bioorg Med Chem. 2015 Sep 1;23(17):5954-71. doi: 10.1016/j.bmc.2015.06.059. Epub 2015 Jun 29. Bioorg Med Chem. 2015. PMID: 26231739 Free PMC article.
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, Luthra S, Garrett TJ, Guingab-Cagmat J, Plant D, Bose P, Cusi K, Hromas RA, Tischler AS, Powers JF, Gupta P, Bibb J, Beuschlein F, Robledo M, Calsina B, Timmers H, Taieb D, Kroiss M, Richter S, Langton K, Eisenhofer G, Bergeron R Jr, Pacak K, Tevosian SG, Ghayee HK. Rai SK, et al. Among authors: bergeron r jr. Metabolism. 2020 Sep;110:154297. doi: 10.1016/j.metabol.2020.154297. Epub 2020 Jun 18. Metabolism. 2020. PMID: 32562798 Free PMC article.
NAAG, NMDA receptor and psychosis.
Bergeron R, Coyle JT. Bergeron R, et al. Curr Med Chem. 2012;19(9):1360-4. doi: 10.2174/092986712799462685. Curr Med Chem. 2012. PMID: 22304714 Free PMC article. Review.
Polyamine-iron chelator conjugate.
Bergeron RJ, McManis JS, Franklin AM, Yao H, Weimar WR. Bergeron RJ, et al. J Med Chem. 2003 Dec 4;46(25):5478-83. doi: 10.1021/jm0302694. J Med Chem. 2003. PMID: 14640556
Fluorescent Lipoprotein Probe.
Bergeron R, Scott J. Bergeron R, et al. Anal Biochem. 1982 Jan 1;119(1):128-34. doi: 10.1016/0003-2697(82)90675-3. Anal Biochem. 1982. PMID: 7072934 No abstract available.
384 results